Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine)

被引:54
作者
Warden, SJ
Bliziotes, MM
Wiren, KM
Eshleman, AJ
Turner, CH
机构
[1] Indiana Univ, Dept Phys Therapy, Indianapolis, IN 46202 USA
[2] Portland VA Med Ctr, Portland, OR USA
[3] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA
[6] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA
关键词
bone density; leptin; neurotransmitter; osteoporosis; SSRI;
D O I
10.1016/j.mce.2005.06.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
There is increasing evidence for a contribution of the neural system to the regulation of bone metabolism. The skeleton is richly innervated by both sympathetic and sensory neurons. While these nerves serve sensory and vascular functions, they are also being found to influence bone cell activities. The most convincing evidence for this has been provided by studies into the skeletal effects of the hormone leptin, which has been shown to centrally regulate bone mass, and through studies into the skeletal effects of hypothalamic neuropeptide Y2 and Y4 receptors. This paper discusses recent evidence for the neural regulation of bone metabolism and, in particular, the potential role of the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT). Recent studies have demonstrated the presence of functional pathways in bone for both responding to and regulating the uptake of 5-HT. This is of high clinical relevance given the role of the serotonergic system in affective disorders, and the wide use of pharmacological agents that target the 5-HT system to manage these disorders. Initial data suggest that exposure to these agents at different stages during the lifespan may have significant effects on the skeleton. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 120 条
[91]   Use of β-blockers and risk of fractures [J].
Schlienger, RG ;
Kraenzlin, ME ;
Jick, SS ;
Meier, CR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1326-1332
[92]   Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies [J].
Schneeweiss, S ;
Wang, PS .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (06) :632-638
[93]   Lumbar bone mineral density in patients with major depression: Evidence of increased bone loss at follow-up [J].
Schweiger, U ;
Weber, B ;
Deuschle, M ;
Heuser, I .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) :118-120
[94]   Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers [J].
Serre, CM ;
Farlay, D ;
Delmas, PD ;
Chenu, C .
BONE, 1999, 25 (06) :623-629
[95]   SEROTONIN AS A REGULATOR OF CRANIOFACIAL MORPHOGENESIS - SITE SPECIFIC MALFORMATIONS FOLLOWING EXPOSURE TO SEROTONIN UPTAKE INHIBITORS [J].
SHUEY, DL ;
SADLER, TW ;
LAUDER, JM .
TERATOLOGY, 1992, 46 (04) :367-378
[96]   Outcomes of prenatal antidepressant exposure [J].
Simon, GE ;
Cunningham, ML ;
Davis, RL .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (12) :2055-2061
[97]   Leptin is a potent stimulator of bone growth in ob/ob mice [J].
Steppan, CM ;
Crawford, DT ;
Chidsey-Frink, KL ;
Ke, HZ ;
Swick, AG .
REGULATORY PEPTIDES, 2000, 92 (1-3) :73-78
[98]   Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter [J].
Stockmeier, CA .
JOURNAL OF PSYCHIATRIC RESEARCH, 2003, 37 (05) :357-373
[99]   Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk [J].
Taddio, A ;
Ito, S ;
Koren, G .
JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (01) :42-47
[100]   Leptin regulates bone formation via the sympathetic nervous system [J].
Takeda, S ;
Elefteriou, F ;
Levasseur, R ;
Liu, XY ;
Zhao, LP ;
Parker, KL ;
Armstrong, D ;
Ducy, P ;
Karsenty, G .
CELL, 2002, 111 (03) :305-317